Please assess the completion status of the following clinical trial:

Trial Title: Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* • Asthmatic children between the ages of 5 and 8 followed at Arkansas Children's Hospital.~  * The subjects must be available to complete the study.~ * The subject's parent(s) and/or the subject's legal guardian must provide written informed consent to participate in the study.~ * The subject must provide assent when older than 7 years old.~ * The subjects should have used a pMDI VHC previously and be able to use a VHC with mouthpiece.~ * The subjects should have been prescribed fluticasone or another inhaled corticosteroid delivered via a pMDI VHC combination.~ * Clinically stable asthma.~ * Cooperative, i.e., subject should be able to follow and understand instructions.~ * The subject must satisfy the study investigator about his/her fitness to participate in the study.~Exclusion Criteria:~* Clinically significant respiratory disease in the previous 4 weeks.~* Participation in any other clinical trial in the previous 4 weeks.~* Lack of cooperation, subject cannot follow and understand instructions.

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 8 Years
- Healthy Volunteers: f

Study Arms:
- Age 5-6.5 (Type: None): Group 1 will consist of 16 children aged 5-6.5 years
- Aged 6.6- 8 years (Type: None): Group 2 will consist of 16 children aged 6.6- 8 years

Based on this trial design, predict the completion outcome and termination type (if applicable).